FoRx Therapeutics AG appoints Ulrich Lücking as Head of Chemistry

Jun 1, 2020

Back to news FoRx Therapeutics AG appoints Ulrich Lücking as Head of Chemistry Basel, Switzerland, 01 June, 2020 – FoRx Therapeutics, a recently incorporated privately-held company developing first-in-class compounds for cancer treatment, today announces the...